Literature DB >> 2189125

Ciprofloxacin. Best use of this new broad-spectrum antibiotic.

R J Fass1.   

Abstract

Resistance to traditional antibiotics is an increasing problem. The introduction of ciprofloxacin (Cipro) has been welcome, because it is safe and effective against many organisms (including drug-resistant ones), can be taken orally, and is well tolerated. Dr Fass provides a complete description of the drug, including its use for infections of the urinary, respiratory, and gastrointestinal tracts; skin and skin structures; and bones and joints.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189125     DOI: 10.1080/00325481.1990.11704677

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  6 in total

Review 1.  Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  J A Balfour; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Are fluoroquinolones safe in children?

Authors:  N K Arora
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

3.  Monitoring of resistance genes in Listeria monocytogenes isolates and their presence in the extracellular DNA of biofilms: a case study from the Czech Republic.

Authors:  Martina Boháčová; Kamila Zdeňková; Zuzana Tomáštíková; Viviana Fuchsová; Kateřina Demnerová; Renáta Karpíšková; Jarmila Pazlarová
Journal:  Folia Microbiol (Praha)       Date:  2018-04-21       Impact factor: 2.099

4.  Ciprofloxacin-loaded dissolving polymeric microneedles as a potential therapeutic for the treatment of S. aureus skin infections.

Authors:  Sharif Abdelghany; Walhan Alshaer; Yazan Al Thaher; Maram Al Fawares; Amal G Al-Bakri; Saja Zuriekat; Randa Sh Mansour
Journal:  Beilstein J Nanotechnol       Date:  2022-06-15       Impact factor: 3.272

5.  Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.

Authors:  Luke Lin; Li-Wen Chang; Cheng-Yuan Tsai; Ching-Hung Hsu; David T Chung; William S Aronstein; Funmi Ajayi; Barbara Kuzmak; Robert A Lyon
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

6.  Vinyl halogenated fatty acids display antibacterial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  David J Sanabria-Rios; Denisse Alequin-Torres; Alenis De Jesus; Giovanni Cortes; Néstor M Carballeira
Journal:  Med Res Arch       Date:  2022-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.